OUR COMMITMENT
Inhalis is committed to
improve patients’ life
with safer and more effective
treatment options
Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases
©2022 INHALIS
All rights reserved.
Policy / Credits